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ABSTRACT 	  
Cardiovascular indices of pain are pervasive in the hospital setting. However, no research 
has examined the development of cardiac responses to acutely painful procedures in the first year 
of life. Our main goal was to synthesize evidence regarding the development of cardiovascular 
responses to acutely painful medical procedures over the first year of life in preterm and term 
born infants. A systematic search retrieved 6994 articles to review against inclusion criteria. A 
total of 41 studies were included in the review. In response to acutely painful procedures, most 
infants had an increase in mean heart rate (HR) that varied in magnitude both across and within 
gestational and postnatal ages. Research in the area of HR variability has been inconsistent, 
limiting conclusions. Accordingly, longitudinal research is needed to further understand the 
inherent variability of cardiovascular pain responses across and within gestational and postnatal 
ages, and the causes for the variability. 
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1. Introduction  
Although skepticism towards infant pain characterized much of the 20th century research 
and clinical practices (Rodkey & Pillai Riddell, 2013), it is now well established that infants’ 
pain transmission pathways in the brain are fully developed by 22 to 24 weeks gestation 
(Schwaller & Fitzgerald, 2014). Conversely, pain inhibitory systems are not fully developed in 
infants, suggesting that infants may feel even more pain than older children (Schwaller & 
Fitzgerald, 2014). Owing to a variety of caregiver, infant and health care practitioner factors (see 
Mitchell, Brooks, & Roane, 2000), emphasis on the assessment and management of infant pain is 
lacking.  
Improper management of acute pain has been associated with various short- and long-
term negative physiological and psychological consequences. Specifically, increased metabolic 
rate during painful experiences has been associated with short-term consequences such as 
exacerbating injury, increased potential for chronic pain, delayed wound healing, increased risk 
of infection, and alterations in pain sensitivity (Denk, McMahon, & Tracey, 2014; Grunau, 2013; 
Kristjansdottir et al., 2012). Additionally, long lasting consequences include delays in motor and 
brain development, as well as deficits in cognition and emotion regulation (Brummelte et al., 
2012; Grunau et al., 2009; Ranger et al., 2013; Valeri, Holsti, & Linhares, 2015; Vinall et al., 
2013; Vinall et al., 2014). Therefore, it is important to establish empirically-based behavioural 
and physiological pain assessment tools that can be utilized in infancy to begin the pain 
management process.  
The major challenge with infant pain assessment is that neonates cannot self-report their 
subjective experience of pain, and there is a lack of agreement on the best modality of assessing 
infant pain, whether it be a cortical, biochemical, physiological, or behavioural measure 
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(Rouzan, 2001).  Moreover, recent work has not only suggested discordance among (Slater et al., 
2008, Slater et al., 2010), but also within, assessment modalities (Pillai Riddell et al. 2013). For 
example, the validity and reliability of physiological measures of infant pain are presently 
disputed, due to these measures being influenced by additional physiological confounders (e.g., 
infection, respiratory rate) (Maxwell, Malavolta, & Fraga, 2013).  
Despite the abovementioned disputes, cardio-physiological indices of pain, such as heart 
rate (HR), and HR variability (HRV), are pervasive in the hospital setting (Grunau et al., 2006). 
Indeed, cardiac measures are well-established noninvasive proxies of cardiac autonomic control, 
and have been integrated in well-established pain assessment tools for preterm and term born 
infants, as well as young children (Ambuel, Hamlett, Marx, & Blumer, 1992; Cignacco, Mueller, 
Hamers, & Gessler, 2004; Gibbins et al., 2014; Hummel, Lawlor-Klean, & Weiss, 2010; Stevens 
et al. 2014; Stevens, Johnston, Petryshen, & Taddio, 1996; van Dijk et al. 2000). However, 
despite this proliferation, there appears to be no research that has longitudinally examined the 
development of cardiac responses to acutely painful procedures in either preterm or term born 
infants. Thus, it is currently unknown how physiological pain regulation develops across the first 
year of life in term born and preterm infants. It is important to better understand the systems 
controlling cardiovascular function, as they are closely coupled with the perception of pain (Faye 
et al., 2010; Bouza 2009).  
The typical developmental pattern of behavioural pain responding suggests that it is 
variable across the first year of life in term born infants (Pillai Riddell et al., 2013). This 
behavioural work demonstrates inherent limits to the validity of averaging over developmental 
stages within infancy (Pillai Riddell et al., 2013). Complicating this picture further, it is 
important to note that the nervous system develops differently in those born at varying levels of 
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prematurity (e.g., Craig et al., 1993; Grunau et al., 2010; Johnston & Stevens, 1996; Singh et al., 
2000), and there is a significant trajectory of cortical, physiological and behavioural development 
over the first years of life (e.g., Chatow, Davidson, Reichman, & Akselrod, 1995; Sugihara, 
Allan, Sobel, & Allan, 1996). Thus, it is crucial to take a more detailed and developmental 
approach to other measurement modalities within the field of infant pain. The purpose of this 
systematic review and meta-analysis is to synthesize existing evidence on the development of 
cardiovascular responses to acutely painful medical procedures over the first year of life in both 
preterm and term born infants. 
2. Method 
 
2.1. Search strategy 
 
 With the assistance of an academic librarian at the University of Toronto, a systematic 
search was conducted in Medline, Embase, PsychINFO, and CINAHL in July 2014 for English-
language references. Searches were limited to articles published from 1970 to 2014 in order to 
encompass historical and contemporary articles and reviews. Search terms related to acute pain 
procedures, cardiovascular measures, and infants (0-3 years of age) were systematically paired 
(See Appendix A). We also hand searched reference lists of relevant studies and systematic 
reviews on cardiovascular responses to acute pain in infants. Our review followed an a priori 
protocol according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009). The review protocol was 
registered on the PROSPERO website before data extraction (registration no. 
CRD42015016398) (Booth, 2013).  
2.2. Inclusion and exclusion criteria and study selection  
We included prospective observational or descriptive studies of individuals equal to or 
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under 3 years of age undergoing an acutely painful procedure, which was monitored using a 
cardiovascular measure. Our definition of observational studies included cohort studies in which 
participants were prospectively identified and followed up during acutely painful procedures 
using cardiovascular indices, as well as cross-sectional studies that observed an acutely painful 
procedure using a cardiovascular measure across different gestational or postnatal ages. We also 
included control group data from pain manipulation studies, and prospective randomized or 
randomized controlled trials (RCTs) that investigated the effectiveness of pain management 
strategies using cardiovascular measures.  
Studies were excluded if they described non-human animal models of pain, did not 
measure an acutely painful event nor included a cardiovascular measure of acute pain, were 
prospective randomized, RCTs, or pain manipulations that did not include a control group, were 
review articles, case studies, or conference abstracts, or studies that included participants that 
differed in age at measurement (i.e., collapsing over one or more months) or gestational age 
(GA) (i.e., collapsing across at least four months GA). Of note, most studies that were discarded 
for collapsing over age of measurement were averaging over age spans within infancy greater 
than 6 months.  
Two authors designed the abstract selection criteria with an initial selection of 500 
abstracts (J.W. and R.P.R.). Three authors (A.P., J.W., and P.T.) independently read and selected 
from all the retrieved references and abstracts. Any disagreements between reviewers were 
resolved through discussion. The percent agreement between the raters ranged from .96 to 1.0. 
Full texts of potentially eligible studies were retrieved (See Figure 1).  
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2.3 Data extraction and quality assessment  
 A database was created recording GA at birth, postnatal age at measurement, a 
description of the cardiovascular results, and any covariates that were included when analyzing 
whether there were differences in cardiovascular measures following an acutely painful medical 
procedure. It was important to investigate covariates included in the studies, as there are a 
number of physiological and behavioural variables known to affect the cardiovascular system 
(Maxwell, Malavolta, & Fraga, 2013).  We reasoned that delving into what variables were 
controlled for might help explain why there is variability in cardiovascular measures. Where 
information was incomplete, the authors were contacted by email.  
Due to a gold-standard quality assessment measure not being available for observational 
studies (see meta-analysis by Sanderson, Tatt, & Higgins, 2007), a modified checklist combining 
Downs and Black (1998) and Crombie (1996) was utilized (See Appendix B). These measures 
were chosen based on a multidisciplinary collaborative review in the field discussing quality in 
case-control, cohort, and cross-sectional studies (Sanderson et al 2007). Fifty percent of the 
extractions were consensus coded for quality scores to ensure reliability.  Disagreements were 
minimal and were resolved through discussion, to obtain a final score for each paper. Criteria 
were scored as “Yes” (1), “No” (0), or “Unable to Determine.” Positively scored criteria were 
added up in order to obtain a total quality score for the paper. The maximum obtainable score for 
the paper was 20 for cross-sectional studies and 21 points for cohort studies. The results were 
expressed as percentages of the total obtainable score.  
2.4. Analysis  
We aimed to synthesize evidence on the development of cardiovascular responses to 
acutely painful procedures in preterm and term born infants. For qualitative analysis, group-
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specific data were first separated by age at measurement, and subsequently subdivided by GA at 
birth, as well as cardiovascular outcome measures (i.e. mean heart rate [HR], HR change, 
maximum HR, low frequency heart rate variability [LF HRV], high frequency heart rate 
variability [HF HRV], low frequency/high frequency ratio [LF/HF ratio]).  
When possible, studies that included mean HR, HR change, maximum HR, LF HRV, HF 
HRV, and/or LF/HF ratio and the standard deviations were then quantitatively analyzed using the 
MEANS procedure in SAS, which computed descriptive statistics for variables within the 
aforementioned GA groups during specific postnatal ages.  
3. Results  
3.1. Studies included  
 We identified 6994 articles from the electronic searches after removal of duplicates. 
These articles were then reviewed by title and abstract, and were included or excluded based on 
a priori selection criteria. A total of 180 articles were then reviewed by full-text review, and of 
these, 41 articles (involving 1552 participants) fulfilled the inclusion criteria (Abad et al., 2001; 
Altun-Koroglu et al., 2010; Bilgen et al., 2001; Bucher et al., 2000; Campos et al., 1994; Cong et 
al., 2009; Cong et al., 2012; Craig et al., 1993; de Jesus et al., 2011; de Oliveira, 2012; Gormally 
et al., 2000; Goubet et al., 2001; Gray et al., 2000; Greenberg et al., 2002; Grunau et al., 2010; 
Haouari et al., 1995; Jatana et al., 2003; Johnston et al., 2007; Johnston et al., 2006; Kostandy et 
al., 2013; Leite et al., 2009; Lindh et al., 2000; Lindh et al., 2003; Lucas-Thompson et al., 2008; 
Oberlander et al., 2002; Oberlander et al., 2002; Oberlander et al., 2005; Ors et al., 1999; Owens 
1984; Sajedi et al 2006; Shibata et al., 2012; Singh et al., 2000; Stevens et al., 1993; Stevens et 
al., 1994; Taksande et al., 2005; Upadhyay et al., 2004; Uyan et al., 2005; Walden et al., 2001; 
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Weissman et al., 2009; Weissman et al., 2012). These studies underwent quality assessment and 
data extraction and were included in the final review. 
3.2. Study characteristics  
 Table 1 provides a detailed overview of the studies included, including sample size, 
country of origin, GA at birth, postnatal age at measurement, acutely painful procedure, 
cardiovascular measure, study design, and quality assessment score.  
 Generally speaking, a quarter of the studies were from Canada, a quarter from the United 
States and a quarter from Europe, with the remaining studies coming from Asia, the Middle East 
and Brazil. The majority of studies were randomized trials, and encompassed infants born 
between 24 to 42 weeks GA, that were tested between postnatal day 1 and postnatal month 4. 
The most common acutely painful procedure that was utilized in the studies was heel stick, and 
mean HR was the most frequently used cardiovascular measure.  In terms of the range of quality 
scores for the papers, the lowest score was 40% (Singh et al., 2000), the median quality score for 
the papers was 75%, and the highest score was 86% (Walden et al., 2001).  
 Age categorizations were difficult to obtain due to the variability between studies in the 
age groups they analyzed.  Based on the available data, the results will be organized by the 
following postnatal ages (i.e. age at measurement): 7 postnatal days or less, 1 to 2 postnatal 
weeks, 3 postnatal weeks, and 1, 2, 3, and 4 postnatal months. Due to the majority of data being 
published on infants within the first 7 postnatal days, tables will only be presented for these 
studies (See Tables 3 to 10). In addition, within each age at measurement category, results will 
then be subdivided by accepted categorizations of GAs (Blencowe et al., 2010) and the 
cardiovascular measures examined.  Due to the large variability in choice of covariates only the 
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presence of covariates will be noted, with a comprehensive list being provided in Table 2 across 
studies.  
3.3. Age at Measurement: Seven Postnatal Days or Less 
3.3.1. Extremely preterm   
25 to 27 Weeks GA. 
Mean Heart Rate: One high quality study used mean HR to describe the acute pain 
experience following a heel stick in those born at 25-27 weeks GA and were measured at 5.50 
postnatal days (Craig et al., 1993). The authors found that that those born at 25-27 weeks GA did 
not have a significant increase in mean HR in response to a heel stick in the first week of life. 
The study found that the mean HR was 172.38 bpm in response to heel stick.  
3.3.2. Very preterm  
28 to 32 Weeks GA. 
Mean Heart Rate: A total of 3 studies investigated the mean HR response to heel stick in 
those born at 28 to 32 weeks GA and measured at 3 to 6 postnatal days (Cong et al., 2009; Craig 
et al., 1993; Lucas-Thompson et al., 2008). The three studies found that heart rate significantly 
increased following the heel stick (Cong et al. 2009; Craig et al., 1993; Lucas-Thompson et al., 
2008). The studies found that mean HR post-acute pain ranged from 155.25 to 169.27 bpm (See 
Table 3). The variability may be due to only one study including covariates (i.e. number of prior 
heel sticks, duration of blood draws, sex, baseline heart rate) in their analysis of the 
cardiovascular measures (Lucas-Thompson et al., 2008). Overall, the studies were generally high 
quality.   
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Heart Rate Change: One lower quality study examined mean HR change in response to 
heel stick at 4 postnatal days (Goubet et al., 2001), and found that HR was significantly higher 
during blood collection compared to baseline HR (See Table 4). 
Heart Rate Variability: One high quality study investigated LF and HF HRV, as well as 
the LF/HF ratio in response to heel stick at 6 postnatal days (Cong et al., 2009). The authors 
found that LF and HF HRV increased in response to heel stick (See Table 5 and 6, respectively), 
while the LF/HF ratio decreased in response to heel stick (See Table 7).  
3.3.3. Moderate to late preterm  
32 to 34 Weeks GA.  
Mean Heart Rate: A total of 4 studies investigated the mean HR response to heel stick 
(Johnston & Stevens, 1996; Lucas-Thompson et al., 2008; Stevens et al., 1993; Stevens et al., 
1994), while 1 study investigated the mean HR response to venipuncture (Singh et al., 2000). All 
studies investigated infants between 3 and 7 postnatal days. Overall, mean HR was found to 
increase in response to acute pain. However, the magnitude of responses was variable and ranged 
from 154-183.4 bpm, with mean HR being higher in the study using venipuncture as the acutely 
painful stimulus. Additionally, variability in the magnitude of mean HR response may be due to 
over half of the studies not including covariates in their analysis (Singh et al., 2000; Stevens et 
al., 2003; Stevens et al., 1994). In the two studies that did include covariates, the authors 
controlled for the frequency of invasive procedures, severity of illness, ventilation status, sex, 
number of prior heel sticks, duration of blood draws, and baseline heart rate. Overall, the quality 
of the studies varied (i.e. 40% compared to 85%).   
Heart Rate Variability: One high quality study investigated mean total HRV in response 
to heel stick at 5 postnatal days or less (Stevens et al., 1994). It was found that total HRV was 
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not significantly different in response to heel stick (See Table 8). However, total HRV 
represented the standard deviation of the mean HR, which may have affected the accuracy of the 
measure.  
34 to 37 Weeks GA.  
Mean Heart Rate: A total of 2 studies investigated mean HR response to heel stick (Craig 
et al., 1993) or venipuncture (Singh et al., 2000). The studies investigated infants at 3 to 7 
postnatal days. In both studies, mean HR increased following the acute pain procedure. Mean 
HR in response to acute pain was found to be 165.3 and 163.2 bpm after heel stick and 
venipuncture, respectively. The quality of the studies was found to vary (i.e. 40% compared to 
85%).  
3.3.4. Full term 
Mean Heart Rate: A total of 9 studies investigated mean HR response to heel stick 
(Campos et al., 1994; Craig et al., 1993; Gormally et al., 2000; Gray et al., 2000; Leite et al., 
2009; Lindh et al., 1999; Oberlander et al., 2002; Shibata et al., 2000; Weissman et al., 2012), 4 
in response to venipuncture (Abad et al., 2001; Lindh et al., 2000; Singh et al., 2000; Taksande et 
al., 2005), and 1 in response to vaccination (Kostandy et al., 2013). The studies investigated 
infants at 0 to 7 postnatal days. Overall, mean HR increased post acute pain procedure; however, 
as in premature infants, the magnitude of the response was variable in term born infants. Mean 
HR ranged from 134 to 174 bpm in response to acute pain. Out of the14 studies investigating 
mean HR response to acute pain, only three included covariates in their analyses (Campos et al., 
1994; Gormally et al., 2000; Oberlander et al., 2002), which again may explain the variability in 
the results. These studies included the number of additional sticks required to obtain the blood 
sample, duration of the heel stick, frequency of crying, average HR, pre-intervention baseline 
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(percentage of time crying in the last two minutes before beginning the interventions), breast-fed 
(yes/no), SSRI exposure (yes/no), age at time of acute pain, maternal analgesia (yes/no), dose of 
SSRI at time of delivery, and dose of clonazepam at time of delivery. Overall, the quality of the 
studies was variable and ranged from low to high quality.  
Maximum Heart Rate: A total of 6 studies investigated maximum HR while infants 
underwent a heel stick procedure at 2 to 7 postnatal days (Altun-Koroglu et al., 2010; Bilgen et 
al., 2001; Campos et al., 1994; de Jesus et al., 2011; Owens 1984; Uyan et al., 2005). Overall, 
maximum HR was found to increase in response to the heel stick, and ranged from 149 to 196 
bpm (Table 9). Two studies included covariates in their analysis (Campos et al., 1994; de Jesus 
et al., 2011), which were the number of additional sticks required to obtain the blood sample, the 
duration of the heel stick, the frequency of crying, the average HR, gestational age, birth weight, 
sex, mode of delivery, diabetic mother (yes/no), breastfed one hour before puncture (yes/no), or 
received oral glucose (yes/no). Overall, the studies were relatively lower in quality (i.e. 60 to 
75%). 
Heart Rate Change: A total of 9 studies investigated mean HR change in response to heel 
stick (Bucher et al., 2000; Gray et al., 2000; Haoari et al., 1995; Jatana et al., 2003; Ors et al., 
1994; Owens, 1984; Uyan et al., 2005; Weissman et al., 2009) and intramuscular injection 
(Sajedi et al., 2006) from 0 to 7 postnatal days. In all studies, mean HR increased significantly in 
response to acute pain. Mean HR was found to increase by 31 to 49 bpm, or between 11 to 38 
percent. Only three studies included covariates in their analysis of the cardiovascular measure 
(Bucher et al., 2000; Owens 1984; Sajedi et al., 2006), which included sex, nurse, number of 
lances needed, baseline heart rate, and activity. The studies included were generally high in 
quality.  
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 Heart Rate Variability: A total of 8 studies investigated mean HF HRV, 6 studies 
investigated LF HRV, and 3 studies investigated the LF/HF ratio or total HRV during heel stick 
(de Oliveria et al., 2012; Gormally et al., 2000; Greenberg et al., 2002; Lindh et al., 2009; 
Oberlander et al., 2002; Weissman et al., 2009, Weissman et al., 2012) or venipuncture (Lindh et 
al., 2000). Total HRV was found to be variable in the two studies, with one study suggesting it 
increases in response to heel stick (Lindh et al., 1999), and the other study suggesting it 
decreases in response to venipuncture (Lindh et al., 2000). It is possible that the two acutely 
painful procedures may have differed in the amount of pain caused. There was also variability in 
HF HRV, with some studies finding HF HRV decreased in response to acute pain (de Oliveira et 
al. 2012; Greenberg et al., 2009; Oberlander et al., 2002; Weissman et al., 2009, 2012), and some 
studies finding no difference in HF HRV in response to acute pain (Gormally et al., 2000; Lindh 
et al., 1999; Lindh et al., 2000). These differences in response patterns may be due in part to the 
heterogeneity of covariates included in four of the studies (de Oliveira et al., 2012; Gormally et 
al., 2000; Greenberg et al., 2009; Oberlander 2002), and the lack of covariates included in the 
four remaining studies (Lindh et al., 1999; Lindh et al., 2000; Weissman et al., 2009; Weissman 
et al., 2012). LF HRV was found to decrease in response to acute pain in four studies (Lindh et 
al., 2000; Oberlander 2002; Weissman et al., 2009, 2012) and increase in one study (Lindh et al., 
1999). Only one study included covariates in their analyses, which may help to explain the 
variability in the results (Oberlander 2002). Finally, the LF/HF ratio was found to increase in the 
three studies (Oberlander et al., 2002; Weissman et al., 2009; Weissman et al., 2012), with only 
one study including covariates in the analysis (Oberlander et al., 2002). These studies included 
infants between 0 and 7 postnatal days, and the studies ranged in quality from 50 to 80%.   
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3.3.5. Quantitative analysis of mean HR 
Due to the variability in measurement strategies across studies, only mean HR was 
amenable to meta-analysis. Separate pooled averages were created to specifically examine mean 
HR differences based on GA at birth in those born at 28-32, 32-34, 34-37, and 37-42 weeks GA. 
Based on the confidence intervals overlapping in all GA groups, the results suggest that pooled 
mean HR responses to acute pain did not statistically differ based on GA at birth (Table 10). 
However, based on certain multimodal pain scales (e.g., PIPP-R; Stevens et al., 2014), full term 
and preterm infants would be in separate score categories for pain, which illustrates clinically 
significant differences in mean HR response to acute pain depending on GA at birth.  
3.3.6. Summary 
Mean Heart Rate: The magnitude of cardiovascular response was variable across GAs, 
with those born at 25 to 27 weeks GA displaying a blunted heart rate response to acute pain, and 
those born at 28 to 42 weeks GA displaying an increase in heart rate across phases. When the 
mean HR responses to acute pain were pooled by GA, they did not significantly differ in those 
born at 28-32, 32-34, 34-37, and 37-42 weeks GA in the first 7 postnatal days of life. However, 
these pooled mean HR responses were significantly different clinically, as the pooled mean HR 
responses would lead to different pain score categories on certain multimodal measures of pain 
for the preterm and term born infants.   
 Mean Heart Rate Change: Mean HR change was utilized in studies investigating infants 
born at 28 to 32 weeks and 37 to 42 weeks GA. Both groups had a significant increase in HR 
following the acutely painful procedure. Maximum HR in response to a heel stick was utilized in 
infants’ born at 37 to 42 weeks GA. All studies found that maximum HR increased in response to 
the heel stick.  
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 Heart Rate Variability: Total HRV, LF HRV, HF HRV, and the LF/HF ratio were 
examined in infants born at 28 to 32, 32 to 34, and 37 to 42 weeks GA. Although LF and HF 
HRV were found to increase, and the LF/HF ratio decreased in response to acute pain in one 
study investigating those born at 28 to 32 weeks GA, clear patterns of HRV in response to acute 
pain could not be deciphered in the later born infants (i.e., 32 to 34 and 37 to 42 weeks GA).  
3.4. Age at Measurement: One to Two Postnatal Weeks 
3.4.1. Extremely preterm 
No studies investigated cardiovascular responses to acute pain in extremely preterm 
infants in the first or second postnatal week of life.  
3.4.2. Very preterm  
28 to 32 Weeks GA.  
Mean HR Change: One lower quality study investigated the mean change in HR 
following a heel stick at one postnatal week (Goubet et al., 2001). The authors found that infants’ 
HR increased by approximately 5 to 10 bpm during the most invasive event of the blood 
collection. One study investigated mean HR change following a heel stick procedure in infants 
who were less than 14 postnatal days old (Cong et al., 2012). During the procedure the authors 
found that mean HR increased significantly from baseline to heel stick procedure, with a mean 
HR change of 22.40 bpm, and standard deviation of 15.42.  
Heart Rate Variability: One high quality study investigated several components of HRV 
in response to a heel stick at 14 postnatal days or less (Cong et al., 2012). The authors reported 
that LF and HF HRV increased in response to heel stick, while the LF/HF ratio decreased in 
response to heel stick. At the time of heel stick, mean LF HRV was reported at 69.84, with a 
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standard deviation of 102.08, mean HF HRV was reported at 24.04, with a standard deviation of 
40.90, and the LF/HF ratio was reported at 23.98, with a standard deviation of 21.39.  
3.4.3. Moderate to late preterm  
32 to 35 Weeks GA 
Mean Heart Rate: One relatively high quality study investigated mean HR in response to 
a heel stick at less than 10 postnatal days (Johnston et al., 2007). Mean heart rate was found to 
increase in response to the heel stick, and was approximately 159 bpm in response to the acute 
pain. A variety of covariates were included in the analysis of the cardiovascular measure, which 
included Apgar scores at 5 minutes, GA at birth, time since last painful procedure, number of 
painful procedures since admission, or received indomethacin in the past 12 hours (yes/no).  
3.4.4. Full term  
Mean Heart Rate: Two studies investigated mean HR response to heel stick (Craig et al., 
1993) or venipuncture (Upadhyay et al., 2004) at less than 15 postnatal days old. Mean HR was 
found to significantly increase in response to venipuncture, and was reported at 163 bpm 
following the acutely painful procedure. In response to heel stick, mean HR was found to 
increase to 145.86 bpm with a standard deviation of 19.22 (Craig et al., 1993). Overall, the 
quality of the studies was high.  
3.4.5. Summary 
Mean Heart Rate: Data were available from studies investigating those born at 28 to 32, 
32 to 35, and 37 to 42 weeks GA during the second postnatal week. Mean HR significantly 
increased in response to acutely painful procedures. The magnitude of heart rate responses was 
variable within and across GA groups.  
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Heart Rate Variability: One study found that infants born at 28 to 32 weeks GA were 
found to have increased LF and HF HRV, and a decreased LF/HF ratio in response to acute pain.  
3.5. Age at Measurement: Three Postnatal Weeks  
3.5.1. Extremely preterm  
24 to 26 Weeks GA. One high quality study investigated the mean and maximum HR 
response following a heel stick at 21 postnatal days (Walden et al., 2001). The authors found that 
mean and maximum HR increased during the heel stick, and was reported as 174.90 bpm with a 
standard deviation of 9.86 bpm, and 175.91 bpm with a standard deviation of 10.35 bpm, 
respectively.  
3.5.2. Very preterm  
No studies investigated cardiovascular responses to acute pain in very preterm infants in 
the third postnatal week of life.  
3.5.3. Moderate to late preterm  
No studies investigated cardiovascular responses to acute pain in moderate to late preterm 
infants in the third postnatal week of life.  
3.5.4. Full term   
No studies investigated cardiovascular responses to acute pain in full term infants in the 
third postnatal week of life.  
3.5.5. Summary  
Mean Heart Rate: In extremely preterm infants, mean and maximum HR were found to 
increase in response to acute pain at 3 postnatal weeks old. The blunted heart rate response that 
was noted in the first seven postnatal days was not found, suggesting an increased response to 
acute pain developing in extremely preterm infants in the first three weeks of life.  
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3.6. Age at Measurement: One Postnatal Month  
3.6.1. Extremely preterm  
24 to 28 Weeks GA.  
Mean Heart Rate:  Two studies with varying quality levels investigated mean HR 
following a heel stick procedure at four postnatal weeks (Johnston & Stevens, 1996; Oberlander 
et al., 2002b). The authors found that there were significant increases in mean HR following the 
heel stick. The approximate mean HR response following the heel stick ranged from 170 to 190 
bpm. A variety of covariates were included in one analysis (Johnston & Stevens, 1996), which 
comprised frequency of invasive procedures, severity of illness, ventilation status, and sex.  
Heart Rate Variability: One study investigated LF and HF HRV and the LF/HF ratio 
during a heel lance procedure (Oberlander et al., 2002b). LF and HF HRV as well as the LF/HF 
ratio decreased during heel lance, and were approximately 5.0, 1.0, and 8.0 during the heel lance, 
respectively.  
3.6.2. Very preterm  
28 to 32 Weeks GA. 
Mean Heart Rate: One high quality study investigated mean HR following a heel stick at 
three to five postnatal weeks (Lucas-Thompson et al., 2008). The authors found that mean HR 
was significantly higher during the heel stick than during recovery, and was reported at 175.94 
bpm, with a standard deviation of 12.66 bpm during the heel stick. The number of prior heel 
sticks, duration of blood draws, sex, and baseline heart rate were included as covariates in the 
analysis.   
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3.6.3. Moderate to late preterm  
No studies investigated cardiovascular responses to acute pain in moderate to late preterm 
infants in the first postnatal month of life.  
3.6.4. Full term  
No studies investigated cardiovascular responses to acute pain in full term infants in the 
first postnatal month of life.  
3.6.5. Summary  
Mean Heart Rate: Data from studies investigating infants at 24 to 28 and 28 to 32 weeks 
GA were available. Both studies found that mean HR increased in response to acute pain. Mean 
HR at one postnatal month was higher in response to acute pain, as compared to the first 7 
postnatal days in those born 28 to 32 weeks GA.  
Heart Rate Variability: At one postnatal month, one study found that LF and HF HRV 
and the LF/HF ratio decreased in response to acute pain.  
3.7. Age at Measurement: Two Postnatal Months 
3.7.1. Preterm Infants  
No studies investigated cardiovascular responses to acute pain in extremely, very, 
moderate to late preterm infants in the second postnatal month of life.  
3.7.2. Full term  
Mean Heart Rate: One relatively lower quality study investigated mean HR responses to 
a heel stick procedure at two postnatal months (Oberlander et al., 2002). The authors found that 
mean HR increased post heel stick, and was approximately 190 bpm during the heel stick. The 
authors included a variety of covariates in their analysis (i.e., breast-fed (yes/no), SSRI exposure 
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(yes/no), age at time of acute pain, maternal analgesia (yes/no), dose of SSRI at time of delivery, 
dose of clonazepam at time of delivery. 
 Heart Rate Variability: The same study investigated mean HRV during the 
aforementioned acute pain procedure (Oberlander et al., 2002). The authors found that during the 
heel stick procedure, LF HRV and the LF/HF ratio decreased, however, there were no significant 
differences in HF HRV. HF and LF HRV, as well as the LF/HF ratio were approximately 4.0, 
28.0, and 8.0 during the heel stick procedure, respectively. The abovementioned covariates were 
used in the analysis. 
3.7.5. Summary 
Mean Heart Rate: One study investigated those born at 37 to 42 weeks GA. Mean HR 
was found to increase in response to acute pain.  
Heart Rate Variability: Although LF HRV and the LF/HF ratio were found to decrease in 
response to pain, HF HRV was not significantly different from baseline to heel stick.  
3.8. Age at Measurement: Three Postnatal Months  
3.8.1 Preterm Infants.   
No studies investigated cardiovascular responses to acute medical procedure pain in 
extremely preterm, very preterm, moderate to late preterm infants in the third postnatal month of 
life.  
3.8.2. Full term  
Mean Heart Rate: One relatively lower quality study investigated mean HR response 
following a heel stick at three postnatal months (Lindh et al., 2003). Mean HR increased post 
heel stick and was approximately 169 bpm during this time.  
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 Heart Rate Variability: The same study investigated mean HRV during the 
aforementioned heel stick procedure (Lindh et al., 2003). In the study, the authors found that 
total HRV and the LF HRV increased during the heel stick, however there were no significant 
differences in HF HRV compared to baseline.  When extrapolating the values, total HRV, HF 
and LF HRV were approximately 4.10, 3.20, and 4.0 during the heel stick procedure, 
respectively. 
3.8.5. Summary  
Mean Heart Rate: Data from one lower quality study investigating those born at 37 to 42 
weeks GA were available. Mean HR was found to increase in response to acute pain. 
Heart Rate Variability: Although total and LF HRV were found to increase in response to 
pain, HF HRV was not significantly different from baseline to heel stick.  
3.9. Age at Measurement: Four Postnatal Months  
3.9.1. Extremely preterm  
24 to 28 Weeks GA 
 Mean Heart Rate: One relatively higher quality study investigated mean HR response 
following immunizations at four postnatal months (Grunau et al., 2010). The authors found that 
mean HR changed significantly across events, with significant increases from the end of baseline 
to first injection, and first injection to third injection. The approximate mean HR during the 
immunizations was 185 bpm. Corrected chronological age was included as a covariate in the 
analysis.  
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3.9.2. Very preterm  
28 to 32 Weeks GA 
Mean Heart Rate: The same study investigated mean HR response following 
immunizations at four postnatal months in infants born at 29 to 32 weeks GA (Grunau et al., 
2010). The authors found that mean HR changed significantly across events, with significant 
increases from the end of baseline to first injection, and first injection to third injection. The 
approximate mean HR during the immunizations was 188 bpm. The abovementioned covariate 
was included in the analysis.  
3.9.3. Moderate to late preterm 
No studies investigated cardiovascular responses to acute pain in moderate to late preterm 
infants in the fourth postnatal month of life.  
3.9.4. Full term  
Mean Heart Rate: One study investigated mean HR response following immunizations at 
four postnatal months in infants born at 38 to 41 weeks GA (Grunau et al., 2010). The authors 
found that mean HR changed significantly across events, with significant increases from the end 
of baseline to first injection, and first injection to third injection. The approximate mean HR 
during the immunizations was 182 bpm. The abovementioned covariate was included in the 
analysis.  
3.9.5. Summary  
Only one cross-sectional, relatively higher quality study (Grunau et al., 2010) 
investigated the effect of GA on mean HR response following immunizations. The authors found 
that there was no effect of GA group (i.e., 24-28, 29-32, and 38-41 weeks GA) on mean HR 
response.  
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4. Discussion  
The purpose of the current review and meta-analysis was to better understand the 
development of cardiovascular responses to acute pain over the first year of life based on GA. 
We also aimed to contrast the available literature to see how acute pain related cardiovascular 
responses differ in those born prematurely compared to those born at term. By way of overview, 
when measuring heart rate, maximum heart rate or heart rate change in the first 7 days of life, the 
range within each age group on these measures became larger as the infant’s GA increased. 
Measures of heart rate variability in the first 7 days of life (using LF HRV or HF HRV) seemed 
to show less variability within age categories as the child’s GA increased, while there was a 
trend towards less variability within an age category in the LF/HF ratio as the infants aged. Data 
from other postnatal age groups (i.e. 2nd week, 3rd week, 1 month, 2 month and 3 months) were 
very sparse with patterns generally impossible to discern due to the total absence or presence of 1 
study. 
The following paragraphs will discuss key findings and patterns in the results of the 
systematic review and meta-analysis with specific attention to GA at birth, age at measurement 
and type of cardiac measurement in response to acutely painful procedures. Comparisons will 
then be drawn across GA groups depending on postnatal age at measurement. Finally, limitations 
and strengths of the review, and key areas for future research based on the findings will be 
highlighted. 
4.1. Extremely preterm 
Studies included infants born extremely premature (i.e.,< 28 weeks GA) who were 
measured at less than seven postnatal days, three postnatal weeks, as well as one and four 
postnatal months. Those born at less than 28 weeks GA displayed a blunted heart rate response 
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to acute pain in the first week of life. By the third and fourth postnatal weeks of life, mean and 
maximum heart rate were found to significantly increase during acutely painful procedures, as 
compared to baseline heart rate. At one postnatal month of life, LF and HF HRV and the LF/HF 
ratio decreased in response to acute pain. Based on one cross-sectional study, this pattern of 
increase was also seen at four postnatal months, where mean HR significantly increased from 
baseline to acutely painful procedure, and was qualitatively higher than during the first postnatal 
month. This synthesis suggests that mean HR responses to acute pain may be stable in extremely 
preterm infants after the first postnatal week of life.  
A blunted pain response in the first week of life based on GA a birth has been noted in 
both physiological and behavioural parameters (Craig et al., 1993; Johsnton, Stevens, Yang, & 
Horton, 1995; Stevens, Johnston, & Horton, 1993). It is possible that the health status of the 
child at birth may affect the infants’ ability to react to invasive procedures during the first week 
of life (Craig et al., 1993). Indeed, infants with the lowest GA have the most health problems 
(e.g., lower birth weights, more oxygen received at delivery, greater use of ventilators at delivery 
and during observation, and greater use of gavage feeding) (Craig et al., 1993), are exposed to 
more invasive procedures (e.g., blood sampling, steroid exposure, suctioning, and routines such 
as weighing and clustered nursing) (Glover, Miles, Matta, Modi, & Stevenson, 2005; Holsti, 
Weinberg, Whitfield, & Grunau, 2007), and are the most developmentally immature (Grunau et 
al., 2010).  
The increase in cardiac responding from baseline that was seen consistently in the first to 
the fourth postnatal month of life suggests that extremely low GA infants begin to demonstrate 
increased physiological responses to acute pain as the cardiovascular system matures (Sugihara 
et al., 1996). Indeed, past research has shown that infants born at 27 weeks GA or less do not 
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have complex or distinctly nonlinear heart rhythms that are consistent with healthy adults 
(Sugihara et al., 1996). Additionally, parasympathetic and sympathetic functions have been 
found to evolve between 27 and 35 weeks gestation (Allan & Sobel, 1992; Chatow, Davidson, 
Reichman, & Akselrod, 1995; Sugihara et al., 1996). Although the relative quality of studies was 
good (76 to 86%), it is important to interpret this qualitative synthesis with caution, given the 
relatively small group of studies (N = 3) that it integrates and the lack of covariates in two of the 
three studies.  
4.2. Very preterm  
 Studies included very preterm (i.e., 28 to < 32 weeks GA) infants measured at less than 
seven postnatal days, one to two postnatal weeks, and one and four postnatal months. In the first 
week of life, mean HR was found to significantly increase immediately following an acutely 
painful procedure. From one to two postnatal weeks, mean HR was found to significantly 
increase in response to acute pain. Significant increases in mean HR were also described at three 
to five postnatal weeks, which were qualitatively higher than at one to two postnatal weeks of 
life. At four postnatal months, infants were found to have significant increases in mean HR in 
response to acute pain. The magnitude of the mean HR response was found to qualitatively 
increase from one to four postnatal months of life. As mentioned above with extremely preterm 
infants, this qualitative increase in mean HR in very preterm infants across the first four postnatal 
months are likely linked to a developmental, relative increase in the parasympathetic 
contribution to HR control (Allan & Sobel, 1992; Chatow et al., 1995; Sugihara et al., 1996).  
  Although HRV components were only investigated in one study of very preterm infants 
in the second postnatal week of life, LF and HF HRV were found to increase, while the LF/HF 
ratio decreased in response to acute pain. This pattern is in line with previous research that found 
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that LF and HF HRV increase during painful procedures (Grunau et al., 2001; Lindh et al., 1999; 
Padhye, Williams, Khattak, & Lasky, 2009). Caution should be taken when interpreting these 
HR and HRV results, as it is based on four studies (quality scores range from 62 to 85%), and a 
single study (quality score: 85%), respectively. Additionally, only one study included covariates 
in their analysis.  
4.3. Moderate to late preterm 
 Cardiovascular indices of acute pain were only examined during the first and second 
postnatal weeks of life in infants born at 32 to less than 37 weeks GA. During the first postnatal 
week of life, mean HR was found to increase in response to acute pain; however, the magnitude 
of responses was variable. Mean HR was found to be stable across the second week of life, and 
increased in response to acute pain. The inconsistencies in mean HR may be due to differences in 
the acute pain procedure (i.e. heel stick versus venipuncture), the variability in quality of studies 
(40 to 85%), and the lack of covariates included in the analyses of more than half of the studies 
(3/5).   
Additionally, when total HRV in response to acute pain was examined in the first week of 
life in those born at 32 to 34 weeks GA, it did not significantly differ from baseline HRV. Given 
that non-linearity in heartbeats, which is necessary to measure HRV, is less apparent before 35 
weeks GA (Sugihara et al., 1996), it is possible that the variance in beat-to-beat rhythms is not 
robust enough to characterize the acutely painful procedure. Moreover, the conclusions are based 
on one study, and although the quality was adequate (75%), there were no covariates included in 
the analysis.  
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4.4. Full term 
 Full term infants’ response to acute pain, as indexed by cardiovascular responses, was 
investigated in the first and second postnatal weeks of life, and during the second, third, and 
fourth postnatal month. During the first postnatal week of life, full term infants displayed an 
increase in mean and maximum HR in response to acute pain; however, the magnitude of 
responses was variable. At two postnatal weeks, full term infants displayed an increase in mean 
HR following an acutely painful procedure; although the studies displayed variable results that 
qualitatively differed based on mean HR in bpm. At two, three and four postnatal months, full 
term infants displayed an increase in mean HR in response to acute pain that peaked during 
postnatal month two. This relative increase in mean HR over the first four postnatal months may 
reflect a developmental, relative increase in the parasympathetic contribution to HR control 
(Chatow et al., 1995). Conversely, the variability in mean HR response across the first four 
months of life may be due to extraneous factors not being accounted for in the majority of 
analyses discussed. For example, respiration has been found to affect modulation of 
instantaneous HR (Chatow et al., 1995). However, this was not included in any of the analyses as 
a covariate. Furthermore, there was only one study per age group at two, three and four postnatal 
months, the study authors included differing or no covariates in their analyses, and the study 
quality ranged from 55 to 76%.  
 During the first postnatal week of life, total HRV was found to be inconsistent, and 
increased and decreased in response to acute pain. In regards to HF HRV, it was also unreliable, 
with studies finding that that it decreased or did not significantly change in response to acute 
pain. LF HRV was also variable, with one study finding it decreased in response to acute pain, 
while the other study found it increased in response to acute pain. The LF/HF ratio was the only 
 	  
 
 
27 
consistent measure of HRV, and it was found to decrease in response to acute pain across 
studies.  
At two postnatal months, LF HRV and the LF/HF ratio decreased in response to acute 
pain. There were no significant differences in HF HRV in response to acute pain at two postnatal 
months of age. At three months of age in response to acute pain, total and LF HRV increased, 
while no differences were found in HF HRV when compared to baseline levels. The synthesis 
suggests that there is stability in the LF/HF ratio from one week to two months of age. However, 
due to this measure being a product of the LF and HF HRV values, all measures of HRV are 
inconsistent across the time points investigated (i.e., postnatal week one to month four).   
The inconsistency within the HRV domains may be explained by the linear statistics 
utilized by authors (Sugihara et al., 1996). Specifically, past research has found that nonlinear 
analysis is superior in discriminating differences in infant heart rhythms when compared to linear 
statistics, such as the mean or variance between heartbeats (Sugihara et al., 1996). As well, only 
one study out of eight included covariates in their analysis, and the quality of the studies varied 
qualitatively (55 to 80%).  
4.5. Comparing preterm and term born infants 
Due to a lack of research across gestational and postnatal ages, a clear comparison of the 
development of cardiovascular responses to acute pain over the first year of life was not possible. 
However, short summaries of the qualitative and quantitative differences in preterm and full term 
infants are described for less than seven postnatal days and four postnatal months.   
During the first postnatal week of life, those born extremely preterm (25 to 27 weeks GA) 
were found to have a blunted cardiovascular response to acute pain, as compared to infants born 
very preterm (28 to 30 weeks GA), moderate to late preterm (31 to 33 and 34 to 36 weeks GA), 
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and full term (37 to 47 weeks GA) (Craig et al., 1993). Qualitatively, there was greater 
variability in mean HR responses to acute pain as GA increased, which has been substantiated in 
previous behavioural pain research in term born infants (Pillai Riddell et al., 2013). Additionally, 
mean HR in response to acute pain was higher in full term compared to moderate to late preterm 
infants (Singh et al., 2000).  Finally, in our own quantitative analysis, pooled mean HR responses 
to acute pain were not statistically different in those born at varying levels of prematurity or 
term. However, it is important to note that these pooled means were clinically significant, as the 
pooled means would lead to infants at differing GA groups being assigned to separate pain 
categories on several assessment tools (e.g., PIPP-R). These inconclusive results are found in the 
general infant pain literature, which has established that preterm infants respond in a manner 
similar to full term neonates (Stevens, Johnston, & Horton, 1993), as well as responding less 
robustly than full term neonates (Johnston et al., 1995).   
During postnatal month four, regardless of GA at birth (i.e., extremely preterm, very 
preterm or full term), infants displayed an increase in mean HR in response to acute pain. 
Moreover, the magnitude of mean HR in response to acute pain did not significantly differ based 
on GA at birth. The results suggest that as the cardiovascular system develops over the first four 
postnatal months of life, mean HR responses to acute pain become similar in those born at 
differing levels of prematurity and at term. However, it is possible that by using an overall mean 
HR to represent infant pain responses, it may have led to misrepresentation of stable subgroups 
within these groups of infants (Pillai Riddell et al., 2013).  
4.6. Limitations of this review 
It is possible that we have omitted relevant studies despite our detailed search strategy, 
and we specifically excluded non-English language studies. Additionally, group-specific data 
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(i.e., age at measurement and GA) were separated based on available data and natural groupings, 
which on occasion led to overlap in GA groups. Furthermore, pooling the means and standard 
deviations of cardiovascular measures based on GA group would have allowed us to investigate 
differences in how the cardiovascular system develops in preterm compared to term born infants. 
However, there are too few studies for this approach to be done, and it could only be completed 
for one-week-old infants.   
Moreover, differences in the methodology for both acquiring and analyzing HR and HRV 
data led to difficulties in making comparisons of cardiovascular measures between GA groups 
and postnatal ages (Padhye et al., 2009). Specifically, there was notable variability in how mean 
HR, HR change, and HRV were calculated over post-acute pain (See Table 11), which may have 
led to increased variability in the cardiovascular measures. Additionally, this variability in the 
timing of events is a limitation for our pooled analyses, as the pooled responses may not being 
measuring the same event. With regards to analyzing HRV, studies differed on spectrum 
calculation methods and models of data analysis. Although terminology such as LF and HF 
bands is common in the field, studies differ on frequency limits of the bands. Other studies 
utilized linear statistical approaches of comparing means and variance, which has been reported 
as less sensitive in classifying HRV in infants (Chatow et al., 1995).   
Furthermore, it was difficult to draw conclusions across development and GA groups for 
cardiovascular responses to acute medical procedure pain, as the majority of studies did not 
include covariates in their analyses that could impact an infants’ cardiovascular response to acute 
pain. It is important to keep in mind that the variability in mean HR and HRV components may 
be due to this lack of control within the studies. Finally, the majority of the studies reviewed in 
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the study were very small sample sizes, all of which were too small to begin to examine 
variability within a GA category at any postnatal age more in-depth.  
4.7. Review Contributions to the Literature   
 To our knowledge, this is the first systematic review and meta-analysis investigating the 
development of cardiovascular indices of acute pain responding across the first year of life.  A 
particular contribution of the methodology pursued was that GA, age at measurement (postnatal 
age), and type of cardiac response was analyzed separately. This is the first systematic review 
and meta-analysis that provides mean and variance for all cardiovascular indices utilized in 
observational and experimental studies of acute pain in infancy. In doing so, the results have 
begun the process of better describing the development of cardiovascular responses to acute 
medical procedure pain.  The large gaps elucidated in this review can provide a framework for 
future research in the field.  In particular, understanding the development of infant pain 
responding outside of the first month of life, with attention to GA at birth still remains largely 
unknown.  Finally, a comprehensive list of covariates utilized in each study has been given, 
which provides researchers with guidelines for future research studies. 
4.8. Implications for research and clinical practice 
In the current review, 41 studies were examined in order to better understand how those 
born prematurely and at term respond to acute pain, as indexed by cardiovascular indices. 
Research across the first four months of life suggest that most infants have an increase in mean 
HR in response to acute pain across gestational and postnatal ages but that the variability within 
a GA category (i.e., extremely preterm, very preterm, moderate to late preterm, full term) 
increases as the GA increases. The presence of variability in heart rate or heart rate change in 
older preterm infants and full term infants presents an important clinical challenge to gold 
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standard measures such as the PIPP-R, N-PASS, COMFORT and Bernese Pain Scale. These 
scales allocate points to preterm infants’ pain score in order to approximate the normal response 
of a full-term infant. However, the synthesis of our review suggests that the variability in heart 
rate responding increases with GA at birth.  
Research in the area of HRV has been inconsistent, and no conclusions can be drawn. 
Furthermore, there is a great amount of variability in the magnitude of HR and HRV responses to 
acute pain within and across GA groups and postnatal age at measurement.  
The results were mixed regarding differences in cardiovascular responses to acute pain 
within the first week of life based on GA group. Pooled means in our meta-analysis did not 
suggest statistically significant differences between mean HR response to acute pain in those 
born at 28 to 32, 32 to 34, 34 to 37, and 37 to 42 weeks GA in the first week of life. However, 
when investigating the individual variability within GA category across the first week of life, 
there are clinically significant increases in the variability of mean HR responses as GA at birth 
increases. Additionally, one study found that those born extremely preterm (25 to 27 weeks GA) 
have a blunted mean HR response to acute pain in the first week of life. Moreover, in another 
study during the first postnatal week of life, very preterm and moderate to late preterm infants 
were found to have an increase in mean HR that was less robust than those born at term. At four 
postnatal months, although mean HR increased in response to acute pain across GA groups (24-
28, 29-32, and 38-41 weeks GA), GA had no effect on mean HR response.  
This information is important for health care providers and researchers, as it suggests that 
cardiovascular indices can vary significantly across gestational and postnatal age groups, and 
should be used in conjunction with behavioural measures to ensure infant pain is being assessed 
and managed properly. It is also important to emphasize that although a blunted cardiovascular 
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response to acute pain in extremely preterm infants was noted, it does not mean that these infants 
are not experiencing pain. Health factors that are specific to those born extremely preterm are 
additional sources of variation in response to acute pain, and we emphasize the need for future 
research that addresses this group of infants systematically (Grunau et al., 2010).   
A lack of control within the studies investigated has been highlighted, with only 13 out of 
41 studies including covariates in their analysis of cardiovascular responses to acute pain. 
Moreover, the covariates utilized in the studies are divergent, which may have increased the 
amount of variability noted in the cardiovascular responses to acute pain. Future research in the 
area of infant pain should address this lack of control by identifying and controlling for factors 
that may affect an infants’ cardiovascular response to acute pain in their own research.  
Examining the studies that did use covariates, key covariates that should seriously be considered 
for inclusion in all cardiac response to pain studies (depending on design) are: gestational age, 
age at measurement (i.e., postnatal age, corrected chronological age), birth weight, time since 
last feeding, ventilation status, baseline (i.e. pre-handling cardiac responding), length of painful 
procedure, number of painful procedures (e.g. how many draw attempts), illness severity, sex, 
and respiration rate.  
Additionally, variability in the analysis of HRV measures has been noted above, and it is 
important to emphasize that measures specifically characterizing the nonlinearity of heart-rate 
time series, and not just their means and variance, may provide more direct and sensitive 
methods for assessing the physiological state of infants (Chatow et al., 1995). 
Overall, our results highlight important gaps where additional research is needed. There 
is a lack of research investigating cardiovascular responses to acute pain in specific gestational 
and postnatal age groups of infants across the first years of life. This is noteworthy, as studies are 
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not attempting to accommodate the inherent variability of cardiovascular pain responses and the 
causes for the variability (Pillai Riddell et al., 2013). 
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Table 1. Study characteristics.  
Study N Country Gestation
al age 
Postnat
al age* 
Acute pain 
procedure 
Cardiovascul
ar measure 
Study 
design 
Quality 
score^ 
 
Abad 
(2001) 
15 Spain 37-42 < 4 
days 
Venipunctur
e 
Mean HR CS; 
Randomized 
trial 
17 
Altun-
Koroglu 
(2010) 
25 Turkey 37-41 4-8 
days 
Heel stick Maximum 
HR 
CS; Double-
blind, 
placebo-
controlled 
trial 
13 
Bilgen 
(2001) 
34 Turkey 37-42 1-9 
days 
Heel stick HR change 
(%) 
CS; 
Randomized 
trial 
14 
Bucher 
(2000) 
20  Switzerlan
d 
37-41 4 days Heel stick  HR change 
(bpm) 
CS; 
Randomized 
trial 
14 
Campos 
(1994) 
20  United 
States 
37-42 2 days  Heel stick Mean HR CS; 
Randomized 
trial 
15 
Cong 
(2012) 
28 United 
States 
28-32 < 14 
days 
Heel stick  HR increase, 
HRV 
CS; 
Randomized 
cross-over 
trial 
17 
Cong 
(2009) 
14 United 
States 
30-32 < 9 
days 
Heel stick  Mean HR, 
HRV 
CS; 
Randomized 
cross-over 
trial 
17 
Craig 
(1993) 
56 Canada 25-27, 
28-30, 
31-33, 
34-36, 
37-42 
< 8 
days 
Heel stick Mean HR CS; 
Observation
al 
17 
de Jesus 
(2011) 
41 Brazil 37-41 < 2 
days  
Heel stick HRV CS; 
Observation
al 
15 
 
 
de 
Oliveira 
(2012) 
36 Brazil 37-41 < 2 
days 
Heel stick Maximum 
HR, HRV 
CS; 
Observation
al 
14 
Gormally 
(2000) 
21 Canada 37-42  2 days  Heel stick Mean HR, 
HRV 
CS; 
Randomized 
controlled 
trial 
15 
Goubet 
(2001) 
14 United 
States 
28-32 4 days, 
21 days 
Heel stick HR change C; 
Observation
al 
13 
 
Gray 
 
15 
 
United 
 
37-42 
 
< 3 
 
Heel stick  
 
Mean HR 
 
CS; 
 
17 
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(2000) States days Randomized 
controlled 
trial 
Greenber
g (2002) 
21 United 
States 
37-42 < 1 day Heel stick Mean HRV CS; 
Randomized 
trial 
13 
Grunau 
(2010) 
13
8 
Canada ≤ 28, 29-
32, 38-41 
4 
months 
Immunizati
on 
Mean HR C; 
Observation
al 
16 
Haouari 
(1995) 
15 England 37-42  < 6 
days 
Heel stick HR change 
(%) 
CS; Double 
blind, 
placebo 
controlled 
trial 
15 
Jatana 
(2003) 
25 India 37-42  < 7 
days  
Heel stick HR change 
(bpm) 
CS; 
Randomized 
trial 
10 
Johnston 
(2007) 
20 Canada 32-35  < 10 
days 
Heel stick Mean HR CS; 
Randomized 
cross over 
trial 
15 
Johnston 
(1996) 
89 Canada 27, 32 4 days, 
5 weeks 
Heel stick Mean HR CS; 
Observation
al 
15 
Kostandy 
(2013) 
19 United 
States 
37-42  1 day Hepatitis B 
Vaccination 
Mean HR CS; 
Randomized 
controlled 
trial 
17 
Leite 
(2009) 
29 Brazil  37-42 < 7 
days 
Heel stick Mean HR CS; 
Randomized 
clinical trial 
17 
Lindh 
(1999) 
25 Sweden 37-42 4-5 
days 
Heel stick Mean HR, 
HRV 
CS; 
Observation
al 
11 
Lindh 
(2000) 
28 Sweden 37-42  3 days  Venipunctur
e  
Mean HR, 
HRV 
CS; 
Randomized
, double 
blind trial 
15 
Lindh 
(2003) 
45 Sweden 37-42 3 
months  
DPT 
Vaccination 
Mean HR, 
HRV 
CS; 
Randomized
, double 
blind, 
controlled 
trial 
14 
Lucas-
Thompso
n (2008) 
49 United 
States  
28-31, 
32-34 
3-5 
days, 3-
5 weeks 
Heel stick Mean HR  C; 
Observation
al 
17 
Oberland
er (2002) 
23 Canada 37-42 2-3 
days 
Heel stick Mean HR, 
HRV 
CS; 
Observation
al 
13 
Oberland 22 Canada 37-42 2 Heel stick Mean HR, C; 13 
 	  
 
 
47 
er (2005) months HRV Observation
al 
Oberland
er 
(2002b)  
12 Canada 24-28 27-54 
days 
Heel stick Mean HR, 
HRV 
CS; 
Observation
al 
11 
Ors 
(1999) 
34 Turkey 37-42 < 9 
days 
Heel stick HR change 
(%) 
CS; 
Randomized 
trial 
15 
Owens 
(1984) 
20 United 
States 
37-42  2 days Heel stick Mean HR CS; 
Observation
al 
12 
Sajedi 
(2006) 
32 Iran 37-42  < 1 day Intramuscul
ar injection 
Mean HR CS; 
Randomized 
trial 
13 
Shibata 
(2013) 
47 Japan 37-42 3-4 
days 
Heel stick Mean HR CS; 
Observation
al 
14 
Singh 
(2000) 
15
0 
India 32-34, 
35-37, 
37-42 
< 7 
days 
Heel stick Mean HR CS; 
Observation
al  
8 
Stevens 
(1993) 
40 Canada 32-34 < 5 
days  
Heel stick Mean HR CS; 
Descriptive 
15 
Stevens 
(1994) 
12
4 
Canada 32-34 ≤ 5 
days 
Heel stick Mean HR, 
Maximum 
HR, HRV 
CS; 
Observation
al 
17 
Taksande 
(2005) 
80 India 37-42  < 7 
days 
Venipunctur
e 
Mean HR CS; 
Observation
al 
11 
Upadhya
y (2004) 
41 India 37-42 <15 
days 
Venipunctur
e 
Mean HR CS; 
Randomized
, placebo-
controlled, 
double-blind 
trial 
16 
Uyan 
(2005) 
21 Turkey 37-42  < 11 
days 
Heel stick  HR change 
(%), 
Maximum 
HR 
CS; 
Randomized 
controlled 
trial 
14 
Walden 
(2001) 
11 United 
States 
24-26 
weeks  
21 days Heel stick Mean HR, 
Maximum 
HR 
C; Quasi-
experimenta
l, repeated 
measures 
18 
Weissma
n (2009) 
29 Israel 37-42 2-3 
days 
Heel stick  HR increase 
(bpm), HRV 
CS; 
Randomized 
trial 
11 
Weissma
n (2012) 
24 Israel  37-42  4-6 
days 
Heel stick  Mean HR, 
HRV 
CS; 
Randomized 
controlled 
trial 
10 
Note. CS= Cross sectional study, C= Cohort study. CS and C Quality Scores are out of 20 and 21, 
respectively. 
 	  
 
 
48 
*Postnatal Age = Age at Measurement 
^ out of 20 or 21 depending on research design 
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Table 2. Description of study covariates included in the cardiovascular analyses.  
Study Covariates 
Abad (2001) N/A 
Altun-Koroglu (2010) N/A 
Bilgen (2001) N/A 
Bucher (2000) Sex, nurse, number of lances needed, baseline heart rate and activity. 
Campos (1994) The number of additional sticks required to obtain the blood sample, the 
duration of the heel stick, the frequency of crying, and the average HR. 
Cong (2012) N/A 
Cong (2009) N/A 
Craig (1993) N/A 
de Jesus (2011) Gestational age, birth weight, sex, mode of delivery, diabetic mothers, 
breastfed one hour before puncture, received oral glucose.  
de Oliveira (2012) PIPP score in the period before the heel prick. 
Gormally (2000) Pre-intervention baseline (percentage of time crying in the last two minutes 
before beginning the interventions). 
Goubet (2001) N/A 
Gray (2000) N/A 
Greenberg (2002) Age, weight, time since last feeding, heel stick and blood collection 
procedure length, and gestational age. 
Grunau (2010) Corrected chronological age.  
Haouari (1995) N/A 
Jatana (2003) N/A 
Johnston (2007) Apgar scores at 5 minutes, gestational age at birth, time since last painful 
procedure, number of painful procedures since admission, or received 
 	  
 
 
50 
indomethacin in the past 12 hours. 
Johnston (1996) Frequency of invasive procedures, severity of illness, ventilation status, sex.  
Kostandy (2013) N/A 
Leite (2009) N/A 
Lindh (1999) N/A 
Lindh (2000) N/A 
Lindh (2003) N/A 
Lucas-Thompson 
(2008) 
Number of prior heel sticks, duration of blood draws, sex, baseline heart 
rate. 
Oberlander (2002) Breast-fed, SSRI exposure, age at time of acute pain, maternal analgesia, 
dose of SSRI at delivery, dose of clonazepam at time of delivery. 
Oberlander (2005) Breast-fed, SSRI exposure, age at time of acute pain, maternal analgesia, 
dose of SSRI at delivery, dose of clonazepam at time of delivery.  
Oberlander (2002b)  N/A 
Ors (1999) N/A 
Owens (1984) Sex.  
Sajedi (2006) Sex. 
Shibata (2013) N/A 
Singh (2000) N/A 
Stevens (1993) N/A 
Stevens (1994) N/A 
Taksande (2005) N/A 
Upadhyay (2004) N/A 
Uyan (2005) N/A 
Walden (2001) N/A 
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Weissman (2009) N/A 
Weissman (2012) N/A 
Note. Not applicable = N/A.  
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Table 3. Mean and standard deviations for heart rate response to acute pain at less than 7 
postnatal days. 
Gestational Age Reference Mean HR (bpm) SD 
25- 27 Weeks     
 Craig (1993) 172.38 17.22 
28-32 Weeks    
 Cong (2009) 165.00 14.00 
 Craig (1993) 168.20 10.50 
 Craig (1993) 155.25 21.57 
 Lucas-Thompson 
(2008) 
169.27 10.89 
32-34 Weeks    
 Singh (2000) 183.40 15.93 
 Stevens (1994) 162.20 15.36 
 Stevens (1993) 154.00 13.00 
 Lucas-Thompson 
(2008) 
158.18 15.19 
34-37 Weeks    
 Craig (1993) 163.20 27.82 
 Singh (2000) 165.30 16.50 
37-42 Weeks    
 Abad (2001)* 170.00 N/A 
 Craig (1993) 145.86 19.22 
 Campos (1994) 174.00 16.60 
 Gormally (2001)* 180.00 N/A 
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 Gray (2009)* 123.00 N/A 
 Kostandy (2013)* 155.00 N/A 
 Leite (2009) 172.70 21.50 
 Lindh (1999) 134.00 19.00 
 Lindh (2000) 144.00 20.00 
 Oberlander (2002)* 168.00 N/A 
 Shibata (2013)* 170.00 N/A 
Note. * denotes numbers that were extrapolated from graphs.  
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Table 4. Mean and standard deviations for heart rate change from baseline in response to acute 
pain at less than 7 postnatal days.  
Gestational Age Reference HR Change SD 
28-32 Weeks    
 Goubet (2001)* 0-15 bpm N/A 
37-42 Weeks    
 Altun-Korglu (2010) 37.00% N/A 
 Bilgen (2001) 19.00% N/A 
 Bucher (2000)* 45 bpm N/A 
 Gray (2000) 36-38 bpm N/A 
 Haoari (1995) 11.40%  3.0 
 Jatana (2003) 31.48 bpm 6.66 bpm 
 Ors (1995) 19.00% N/A 
 Owens (1984) 49.00 bpm 17.5 bpm 
 Sajedi (2006) 10.81  N/A 
 Uyan (2005) 38.20% N/A 
 Weissman (2009) 36.50 bpm 19.50 bpm 
Note. * denotes numbers that were extrapolated from graphs.  
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Table 5. Mean and standard deviations for low frequency heart rate variability in response to 
acute pain at less than 7 postnatal days. 
 
Gestational Age Reference Mean LF HRV  SD 
28-32 Weeks    
 Cong 2009 
 
17.62 24.55 
37-42 Weeks     
 Gormally (2001)* 
 
1.65 N/A 
 Lindh (1999) 
 
4.2 0.4 
 Lindh (2000) 
 
4.00 0.39 
 Oberlander (2002)* 
 
11.0 N/A 
 Weissman (2012) 
 
1.45 0.38 
Note. Heart rate variability = HRV, low frequency = LF, standard deviation = SD.  
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Table 6. Mean and standard deviations for high frequency heart rate variability in response to 
acute pain at less than 7 postnatal days. 
 
Gestational Age Reference Mean HF HRV  SD 
28-32 Weeks    
 Cong (2009) 
 
23.52 35.96 
37-42 Weeks     
 de Oliveira (2012) 
 
.44 .69 
 Greenberg (2002)* 
 
2.5 N/A 
 Lindh (1999) 
 
3.4 0.60 
 Lindh (2000) 
 
3.23 0.45 
 Oberlander (2002)* 
 
2.0 N/A 
 Weissman (2012) 
 
0.76 0.50 
Note. Heart rate variability = HRV, high frequency = HF, standard deviation = SD.  
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Table 7. Mean and standard deviations for low frequency/high frequency ratio in response to 
acute pain at less than 7 postnatal days. 
Gestational Age Reference Mean LF/HF Ratio  SD 
28-32 Weeks    
 Cong (2009) 
 
1.75 1.84 
37-42 Weeks     
 Oberlander (2002)* 
 
6.00 N/A 
 Weissman (2012) 
 
6.1 3.2 
Note. Low frequency = LF, high frequency = HF, standard deviation = SD.  
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Table 8. Mean and standard deviations for total heart rate variability in response to acute pain at 
less than 7 postnatal days. 
Gestational Age Reference Mean Total HRV SD 
32-34 Weeks    
 Stevens (1994) 4.52 2.95 
37-42 Weeks    
 Lindh (1999) 4.30 0.40 
 Lindh (2000) 4.10 0.35 
Note. Heart rate variability = HRV, standard deviation = SD.  
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Table 9. Mean and standard deviations for maximum heart rate in response to acute pain at less 
than 7 postnatal days. 
Gestational Age Reference Maximum HR (bpm) SD 
37-42 Weeks    
 Campos (1994) 192.00 11.80 
 de Jesus (2011) 149.00 N/A 
 Owens (1984) 179.40 13.40 
 Singh (2000) 160.30 20.00 
 Taksande (2005) 151.00 10.40 
 Uyan (2005) 186.00 N/A 
Note. Beats per minute = bpm, heart rate = HR, standard deviation = SD.  
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Table 10. Confidence limits, pooled means and standard deviations for mean heart rate at less 
than 7 postnatal days based on gestational age. 
Gestational 
Age (wks) 
Studies (n) Lower 95% 
CL 
Upper 95% 
CL 
Mean SD 
28-32 4 162.52 172.9 
 
167.71 
 
0.62 
 
32-34 4 147.68 
 
176.64 
 
162.16 
 
3 
34-37 2 150.26 
 
178.9 
 
164.58 
 
0.36 
 
37-42 7 142.45 
 
167.25 
 
154.85 
 
3.10 
 
Note. Confidence limit = CL, standard deviation = SD. Heart rate reported in beats per minute 
(bpm).  
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Table 11. Timing of Mean HR, HR change, and HRV calculations. 
Study Time of measurement  
Abad (2001) 0-120 seconds post-needle procedure.  
Altun-Koroglu (2010) Difference between baseline and maximum HR. 
Bilgen (2001) 0-60 seconds post-needle procedure. 
Bucher (2000) Difference between baseline and maximum HR. 
Campos (1994) 0-15 seconds post-needle procedure.  
Cong (2012) 0-30 seconds post-needle procedure.  
Cong (2009) 0-15 seconds post-needle procedure. 
Craig (1993) 0-10 seconds post-needle procedure. 
de Jesus (2011) 0-180 seconds post-needle procedure.  
de Oliveira (2012) 15 seconds pre-needle to 30 seconds post-needle 
procedure.  
Gormally (2000) 0-60 seconds post-needle procedure. 
Goubet (2001) 0-30 seconds post-needle procedure.  
Gray (2000) 0-10 seconds post-needle procedure.  
Greenberg (2002) 0-300 seconds post-needle procedure.  
Grunau (2010) 0-30 seconds post-needle procedure. 
Haouari (1995) Difference between baseline and maximum HR. 
Jatana (2003) Difference between baseline and maximum HR.  
Johnston (2007) 0-30 seconds post-needle procedure.  
Johnston (1996) 0-15 seconds post-needle procedure.  
Kostandy (2013) 0-60 seconds post-needle procedure.  
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Leite (2009) 0-250 seconds post-needle procedure  
Lindh (1999) 0-40 seconds post-needle procedure.  
Lindh (2000) 0-80 seconds post-needle procedure.  
Lindh (2003) 0-45 seconds post-needle procedure. 
Lucas-Thompson (2008) 0-30 seconds post-needle procedure.  
Oberlander (2002) 20-160 seconds post-needle procedure.  
Oberlander (2005) 20-160 seconds post-needle procedure. 
Oberlander (2002b)  20-160 seconds post-needle procedure. 
Ors (1999) Difference between baseline and maximum HR. 
Owens (1984) 0-15 seconds post-needle procedure.  
Sajedi (2006) Difference between mean HR before and after 
needle procedure.  
Shibata (2013) 0-2 seconds post-needle procedure.  
Singh (2000) Maximal change post-needle procedure.  
Stevens (1993) 0-15 seconds post-needle procedure.  
Stevens (1994) 0-15 seconds post-needle procedure.  
Taksande (2005) Maximal change post-needle procedure. 
Upadhyay (2004) 0-60 seconds post-needle procedure.  
Uyan (2005) 0-60 seconds post-needle procedure. 
Walden (2001) 0-30 seconds post-needle procedure.  
Weissman (2009) 10-130 seconds post-needle procedure.  
Weissman (2012) 10-130 seconds post-needle procedure. 
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Figure 1. Included study flow chart following PRISMA guidelines. 
 
 
 
PRISMA 2009 Flow Diagram 
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APPENDIX A 
 
Medline Search Strategy  
 
1. Acute pains/ 
2. acute pain*.mp. 
3. (bloodsampl* or immuni* or inoculat* or vaccin* or inject* or "finger prick*" or finger-prick 
or "heel prick*" or heel-prick* or "heel lance*" or heel-lance* or "heel puncture*" or heel-
puncture* or "heel stick" or suture* or (laceration* adj3 repair*)).mp. 
4. ("lumbar puncture" or lumbar-puncture* or "spinal tap*" or spinal-tap*).mp. 
5. ("bone marrow aspiration" or "bone marrow biops*").mp. 
6. (intravenous or intra-venous or venepuncture* or venipuncture* or venous cannulation* or 
(arterial blood gas* and cannul*)).mp. 
7. ((catheter adj6 insert*) or catheter* or port-a-cath* or portacath).mp. 
8. ("central line" adj6 (insert* or remov*)).mp. 
9. (central venous catheter* adj6 insert*).mp. 
10. (localanalges* or local anaesthe* or local anesthe*).mp. 
11. ((arterial puncture or artery) adj6 puncture*).mp. 
12. "arterial line*".mp. 
13. (thoracocentesis or paracentesis).mp. 
14. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 
15. exp Pain/ 
16. Pain Measurement/ 
17. PAIN THRESHOLD/ 
18. pain*.mp. 
19. 15 or 16 or 17 or 18 
20. 14 and 19 
21. ((vaccin* adj6 pain) or (cannul* adj6 pain) or (acute pain* adj6 pain*) or (procedure* adj6 
pain*) or (procedure-related adj6 pain)).mp. 
22. 20 or 21 
23. Child, Preschool/ 
24. exp Infant/ 
25. (baby or babies or neonate* or newborn or child* or infant* or paediatric* or pediatric*).mp. 
26. 23 or 24 or 25 
27. 22 and 26 
28. Heart Rate/ 
29. (physiology or physiological).mp. 
30. heart rate variability.mp. 
31. Psychophysics/ 
32. Autonomic Nervous System/ 
33. vagal tone.mp. 
34. Electrocardiograph*.mp. 
35. low frequency.mp. 
36. high frequency.mp. 
37. (biobehaviour or biobehavior).mp. 
38. respiratory sinus arrhythmia.mp. 
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39. respirat*.mp. 
40. (spectral analysis or spectrum analysis).mp. 
41. (frequency domain measures or frequency domain analysis).mp. 
42. Arterial Pressure/ 
43. 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39 or 40 or 41 or 42 
44. 27 and 43 
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APPENDIX B 
 
Quality Assessment Measure 
 
1. Is the hypothesis/aim/objective of the study clearly described? 
 
2. Are the main outcomes to be measured clearly described in the Introduction or 
Methods section? 
 
3. Is the design of the study described? 
 
4. Is the setting of the study described? 
 
5. Is the source of the subjects studied stated? 
 
6. Is the distribution of the study population by age described? 
 
7. Is the distribution of the study population by gender described? 
 
8. Is the sample size stated? 
 
9. Is the participation/follow up described? 
 
10. Are non-participants/subjects lost to follow up described? 
 
11. Are the main findings of the study clearly described? 
 
12. Are the statistical methods described? 
 
13. Have actual probability values been reported (e.g., 0.035 rather than < 0.05) for the 
main outcomes except where the probability value is less than 0.001? 
 
14. Are confidence intervals/standard deviations given? 
 
15. Are any conclusions stated? 
 
16. Were the subjects asked to participate in the study representative of the entire 
population from which they were recruited? 
 
17. Were the subjects who were prepared to participate in the study representative of the 
entire population from which they were recruited? 
 
18. Was the participation/follow-up rate > 80%? 
 
19. Were the main outcome measures used accurate (valid and reliable)? 
 
20. Was the sample size justified? 
 
21. Analysis adjusts for length of follow up?  
 
